Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 13 August

Bell Direct
August 13, 2024

Morning Bell 12 August

Grady Wulff
August 12, 2024

Weekly Wrap 9 August

Grady Wulff
August 9, 2024

Morning Bell 9 August

Sam Kanaan
August 9, 2024

Morning Bell 8 August

Bell Direct
August 8, 2024

Morning Bell 31 July

Sam Kanaan
July 31, 2024

Morning Bell 30 July

Sam Kanaan
July 30, 2024

Morning Bell 29 July

Grady Wulff
July 29, 2024

Weekly Wrap 26 July

Grady Wulff
July 26, 2024

Morning Bell 26 July

Sam Kanaan
July 26, 2024

Morning Bell 25 July

Grady Wulff
July 25, 2024